This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks to Watch: Tiffany, Adobe, Targacept (Update 1)

NEW YORK -- Tiffany (TIF) missed analysts' estimates on holiday profit as sales growth fell, hurt by declining sales in Europe and the U.S..

The luxury retailer's fourth-quarter net income fell 1.6% to $178.4 million, or $1.39 a share. Analysts had forecast $1.42 a share.

However, the retailer announced a higher-than-expected earnings forecast for the year. It expects profit of $4.05 a share for the year ending Jan 31, 2013. Analysts are looking for $3.92.

Tiffnay shares were up 3% to $70.75 in premarket trading Tuesday.


The fast food chain Wendy's (WEN) surpassed Burger King as the second biggest fast-food chain.

Wendy's total sales came in at $8.5 billion for 2011, higher than $8.4 billion for its competitor. However, McDonald's remains at the top, with sales of $34.2 billion.

The numbers are from food consulting firm Technomic.

Shares of Wendy's were up 1% to $5.08.


Adobe Systems (ADBE), a maker of digital media publishing and marketing applications, posted fiscal first quarter profit in line with analysts' estimates.

Adobe posted non-GAAP profit of $284.5 million, or 57 cents a share, on revenue of $1.045 billion. Analysts were expecting earnings of 57 cents a share on revenue of $1.053 billion.

For the fiscal second quarter ending in May, Adobe forecast non-GAAP earnings of 57 cents to 61 cents a share on revenue ranging from $1.09 billion to $1.14 billion. The current average analysts' view is for a profit of 60 cents a share on revenue of $1.10 billion.

Shares were down 3.9% to $33.15 in premarket trading.


AstraZeneca (AZN)and Targacept (TRGT) announced they will no longer go forward with plans to develop an experimental antidepressant following an unsuccessful late-stage clinical trial. The drug, called TC-5214, failed to show effectiveness compared to placebo when given to depressed patients.

Some analysts had cut their expectations for the drug, so the announcement was not a surprise. Still the drug was a lead product candidate for Targacept.

Shares of the company were plunging almost 13% to $6.40, while shares of AstraZeneca were down 1% to $44.95.


Amazon.com (AMZN) agreed to acquire privately held Kiva Systems, a maker of robotic package handling systems for $775 million in cash.

Separately, Amazon will be selling $10 gift cards for $5 on Tuesday to people who visit AmazonLocal.com, its answer to deals sites such as Groupon and LivingSocial, The Associated Press reported.

Shares were down 0.7% to $184.18.


Goldman Sachs (GS)has begun a new round of staff cuts in its trading and investment banking divisions, Reuters reported, citing three sources familiar with the matter. .

Goldman eliminated 2,400 positions last year, and the sources said further reductions are possible as the company continues to reduce costs.

The investment bank's latest round of cuts is part of its annual employee review process.

Shares were off 0.6% to $123.50.


Oracle (ORCL), the database software giant, is expected by analysts Tuesday to earn 56 cents a share in its fiscal third quarter on revenue of $9.02 billion.

Wall Street will be looking to see if the massive expansion of Oracle's sales force that took place in the first half of the company's hiscal year has paid off in the third quarter. Shares were down 0.4% to $29.63.


Walt Disney (DIS) said it expects to record an operating loss of $200 million in its fiscal second quarter ending in March stemming from the poor performance of the movie John Carter.

Shares were down 1% to $43.01.


-- Written by Joseph Woelfel and Chao Deng.

>To contact the writer of this article, click here: Joseph Woelfel

Related links:
Onyx Pharma: An Underdog Worth Buying


Apple Dividend: Fueling New Highs

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs